Universal Health International Group Holding Limited (HKG:2211)
0.0870
-0.0010 (-1.14%)
Apr 29, 2025, 3:34 PM HKT
HKG:2211 Revenue
Universal Health International Group Holding had revenue of 441.15M CNY in the half year ending December 31, 2024, a decrease of -44.65%. This brings the company's revenue in the last twelve months to 938.85M, down -13.98% year-over-year. In the fiscal year ending June 30, 2024, Universal Health International Group Holding had annual revenue of 1.09B, down -16.04%.
Revenue (ttm)
938.85M CNY
Revenue Growth
-13.98%
P/S Ratio
0.07
Revenue / Employee
730.06K CNY
Employees
1,286
Market Cap
70.49M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 1.09B | -208.00M | -16.04% |
Jun 30, 2023 | 1.30B | 23.46M | 1.84% |
Jun 30, 2022 | 1.27B | 88.40M | 7.46% |
Jun 30, 2021 | 1.19B | -324.96M | -21.52% |
Jun 30, 2020 | 1.51B | -914.29M | -37.71% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
Sino Biopharmaceutical | 30.72B |